CN112006273B - Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof - Google Patents
Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof Download PDFInfo
- Publication number
- CN112006273B CN112006273B CN202010506274.3A CN202010506274A CN112006273B CN 112006273 B CN112006273 B CN 112006273B CN 202010506274 A CN202010506274 A CN 202010506274A CN 112006273 B CN112006273 B CN 112006273B
- Authority
- CN
- China
- Prior art keywords
- powder
- meal replacement
- content
- replacement powder
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 154
- 235000012054 meals Nutrition 0.000 title claims abstract description 72
- 150000002576 ketones Chemical class 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 39
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 31
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 27
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 27
- 235000020985 whole grains Nutrition 0.000 claims abstract description 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 22
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 239000006041 probiotic Substances 0.000 claims abstract description 20
- 235000018291 probiotics Nutrition 0.000 claims abstract description 20
- 230000036961 partial effect Effects 0.000 claims abstract description 19
- 235000019197 fats Nutrition 0.000 claims description 47
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 30
- 229930195729 fatty acid Natural products 0.000 claims description 30
- 239000000194 fatty acid Substances 0.000 claims description 30
- 150000004665 fatty acids Chemical class 0.000 claims description 30
- 235000014571 nuts Nutrition 0.000 claims description 30
- 235000014633 carbohydrates Nutrition 0.000 claims description 26
- 239000000047 product Substances 0.000 claims description 21
- 235000018102 proteins Nutrition 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 12
- 108090001060 Lipase Proteins 0.000 claims description 11
- 102000004882 Lipase Human genes 0.000 claims description 11
- 239000004367 Lipase Substances 0.000 claims description 11
- 230000009286 beneficial effect Effects 0.000 claims description 11
- 235000019421 lipase Nutrition 0.000 claims description 11
- 230000000968 intestinal effect Effects 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 9
- 229920002752 Konjac Polymers 0.000 claims description 9
- 230000002361 ketogenic effect Effects 0.000 claims description 9
- 235000010413 sodium alginate Nutrition 0.000 claims description 9
- 239000000661 sodium alginate Substances 0.000 claims description 9
- 229940005550 sodium alginate Drugs 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 241000193749 Bacillus coagulans Species 0.000 claims description 8
- 229940054340 bacillus coagulans Drugs 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 102000007544 Whey Proteins Human genes 0.000 claims description 7
- 108010046377 Whey Proteins Proteins 0.000 claims description 7
- 230000000996 additive effect Effects 0.000 claims description 7
- 239000000252 konjac Substances 0.000 claims description 7
- 238000005809 transesterification reaction Methods 0.000 claims description 7
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 239000002199 base oil Substances 0.000 claims description 6
- 239000013067 intermediate product Substances 0.000 claims description 6
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 6
- 230000000529 probiotic effect Effects 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 5
- 235000009496 Juglans regia Nutrition 0.000 claims description 5
- 244000199866 Lactobacillus casei Species 0.000 claims description 5
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 5
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 5
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 229940017800 lactobacillus casei Drugs 0.000 claims description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 5
- 235000020234 walnut Nutrition 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 238000000199 molecular distillation Methods 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 2
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 2
- 229920002581 Glucomannan Polymers 0.000 claims description 2
- 108010084311 Novozyme 435 Proteins 0.000 claims description 2
- 229940046240 glucomannan Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 235000013406 prebiotics Nutrition 0.000 abstract description 9
- 230000002195 synergetic effect Effects 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000037353 metabolic pathway Effects 0.000 abstract description 3
- 230000037208 balanced nutrition Effects 0.000 abstract description 2
- 235000019046 balanced nutrition Nutrition 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 23
- 235000005911 diet Nutrition 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- 235000013350 formula milk Nutrition 0.000 description 15
- 235000013312 flour Nutrition 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 14
- 210000001035 gastrointestinal tract Anatomy 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 229940088594 vitamin Drugs 0.000 description 12
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 6
- 102000016267 Leptin Human genes 0.000 description 6
- 108010092277 Leptin Proteins 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000003797 essential amino acid Substances 0.000 description 6
- 235000020776 essential amino acid Nutrition 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 235000003642 hunger Nutrition 0.000 description 6
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 6
- 229940039781 leptin Drugs 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 240000007472 Leucaena leucocephala Species 0.000 description 5
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 229960001231 choline Drugs 0.000 description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 5
- 239000011651 chromium Substances 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 235000020887 ketogenic diet Nutrition 0.000 description 5
- 235000019823 konjac gum Nutrition 0.000 description 5
- 235000020903 low-carbon-diet Nutrition 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000011572 manganese Substances 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000004386 Erythritol Substances 0.000 description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 4
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010033307 Overweight Diseases 0.000 description 4
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 4
- 239000004376 Sucralose Substances 0.000 description 4
- 235000019577 caloric intake Nutrition 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 229940009714 erythritol Drugs 0.000 description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 4
- 235000019414 erythritol Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 4
- 201000008980 hyperinsulinism Diseases 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000001007 puffing effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 4
- 235000019408 sucralose Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000021329 brown rice Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000021074 carbohydrate intake Nutrition 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002641 glycemic effect Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 229940071440 soy protein isolate Drugs 0.000 description 3
- 229940083466 soybean lecithin Drugs 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- 235000001543 Corylus americana Nutrition 0.000 description 2
- 240000007582 Corylus avellana Species 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- 241000371652 Curvularia clavata Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 244000307700 Fragaria vesca Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 229910001297 Zn alloy Inorganic materials 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000004066 metabolic change Effects 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 235000020610 powder formula Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- -1 aromatic amino acid Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000001009 nucleus accumben Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000019587 texture Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000004515 ventral tegmental area Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Abstract
The application discloses healthy lipid-reducing meal replacement powder without ketone production and a preparation method thereof; wherein, a healthy lipid-reducing meal replacement powder without ketone production, wherein: in the meal replacement powder, the energy supply ratio of the carbohydrate is 17-25%, the energy supply ratio of the protein is 25-40%, the energy supply ratio of the fat is 25-38%, and the energy supply ratio of the dietary fiber is 13-20%, and the meal replacement powder has balanced nutrition, so that a human body takes fat as an energy source preferentially, the metabolic pathway of the human body can be regulated and controlled accurately, and the generation of ketone bodies is avoided, thereby achieving the purposes of health and fat reduction. The formula of the application innovates various creative processes to obtain medium-long carbon chain triglyceride with low partial glyceride content, and the dietary fiber proportion, the prebiotics, the multifunctional mixed probiotics and the like of the whole grain powder, the fruit powder and the nut powder which are easy to brew have the maximum synergistic effect, so that various functional components can play the best effect.
Description
Technical Field
The application belongs to the technical field of functional foods, and particularly relates to healthy lipid-reducing meal replacement powder free of ketone production and a preparation method thereof.
Background
Obesity is an important cause of chronic diseases such as cardiovascular and cerebrovascular diseases, cancers, diabetes mellitus and the like, and is one of ten diseases which threaten human health by the world health organization. According to the statistical mathematics of the world health organization, the number of overweight people in the world exceeds 10 hundred million, and more than 3 hundred million people are severely obese, and the obesity proportion of developing countries is greatly increased. In China, according to the investigation results of nutrition and health conditions published by the Ministry of health, the Ministry of science and technology and the national statistical bureau, 2 hundred million people in 13 hundred million people in China are overweight, and especially overweight of children is rapidly growing. Thus, weight control is a significant problem facing the world. The recommended intervention means for increasing physical activity and reducing total energy intake are correct and effective, but have slower effect, insufficient compliance and are difficult to persist for a long time.
At present, the carbohydrate content in the Chinese diet is relatively high. High carbohydrate diets tend to increase insulin secretion. Insulin is a key hormone that promotes anabolism and fat storage. Insulin stores energy as fat sequestered within adipose tissue, so that energy is not oxidatively utilized by metabolically active tissues, resulting in an intracellular starvation condition. Hunger sensation and appetite reactivity are enhanced, caloric intake is increased, energy is balanced, and fatness is generated. Reducing insulin level, improving cardiovascular metabolism, and reducing body weight. It is generally believed that hyperinsulinemia is secondary to obesity and may be primary in nature, originating from autonomic dysfunction. Obesity is also a leptin resistant state, with defects in leptin signaling promoting caloric intake to maintain normal energy expenditure; insulin acts as an antagonist of endogenous leptin, sharing a central signaling pathway with leptin; inhibiting insulin reduces leptin resistance, thereby reducing caloric intake and increasing voluntary activity. Hyperinsulinemia also interferes with dopamine clearance in the ventral tegmental area and nucleus accumbens, promoting an elevated food reward. Hyperinsulinemia promotes weight gain by the following mechanisms: promoting energy entry into adipose tissue, interfering with leptin signaling, interfering with the regression of food hedonic responses.
Hyperinsulinemia is a necessary consequence of high carbohydrate intake, which inhibits release of fatty acids into the blood in adipose tissue by elevating insulin secretion, anchors fat in adipose tissue, and guides fat in blood circulation into adipose tissue for storage. Metabolically active organ tissues such as heart, muscle, liver, from blood circulation, have reduced available fatty acids, placing these cells in a starvation state, leading to reduced adaptive energy expenditure, increased food intake. Reducing the ratio of carbohydrate to fat energy in food can reduce insulin secretion, increase fat mobilization in adipose tissue, and promote oxidation of free fatty acids in blood circulation. This change in metabolic and endocrine environments is therefore expected to reduce intracellular starvation, reduce hunger sensation, increase body fat loss, and increase energy expenditure. Another possible mechanism for weight loss in low carbon diets is that fat and protein increase satiety, reduce accompanying hypoglycemia, and in turn reduce hunger, reduce total food intake, and produce active energy deficit. The 3 rd mechanism of low carbon diets is that low carbon diets produce a higher metabolic burn than high carbon diets, with an additional 200-300 kcal burn compared to an isocaloric high carbon diet.
The average daily carbohydrate intake varies widely from race to race, so it is very difficult to have a common low carbon standard worldwide. Average carbohydrate intake of 45% (energy source) for most national residents since most cases where carbohydrate is less than 45% are not subject to any metabolic change, carbohydrate is so low that it is a meaningful low-carbon diet when it is capable of producing metabolic changes, i.e. burning fat. Currently, the carbohydrates in the diet are classified into 4 and so on according to the ratio of carbohydrates in total intake energy: (1) very low-carbon (VLC): carbohydrate accounts for less than 10% of total energy, i.e. ketogenic diet; (2) low-carbon (LC): the carbohydrate accounts for less than 26% of the total energy; (3) medium-carbon (MC): the carbohydrate accounts for 26-44% of the total energy; (4) high-carbon (HC): the carbohydrate content is 45% or more of the total energy. When the total energy proportion of carbohydrate in the diet is less than 26%, the functional mode of the organism is changed, and the diet is changed from depending on glucose to depending on fatty acid and ketone body.
The current popular ketogenic diet weight-losing method belongs to extremely low-carbon diet, mainly uses fat to provide energy, and the fat content accounts for 70% -75%. Fatty acids undergo beta oxidation in vivo to acetyl-coa, which needs to be combined with oxaloacetate for complete oxidation into the tricarboxylic acid cycle. In ketogenic diets, most of the acetyl-coa is metabolized to ketone bodies due to the lack of carbohydrates, which is insufficient in oxaloacetate in humans. The ketone body contains 3 components: acetoacetic acid, beta-hydroxybutyric acid and acetone. In the starved or ketogenic state of the human body, fatty acids supply energy to muscles and other tissues, but they cannot enter the brain, and ketogenic amino acids in the liver and ketone bodies produced by fatty acids supply another energy to the brain through transport carriers. Normally, ketone bodies in blood are very tiny, and if ketone bodies in blood are too high and ketone bodies in urine appear, certain health or life risks can exist for patients with some diseases, especially invisible diseases. People who lose weight through ketogenic diet have good initial weight-loss effect, but the proportion of people who can keep weight-loss results is only 1%. Compliance is too poor and only short term lipid-lowering effects make ketogenic diets less effective in weight management.
At present, related patents report meal replacement powder for losing weight and reducing blood fat, but the prior patent technology basically adopts the efficacy of one or a plurality of components to achieve the purpose of losing weight and reducing blood fat, and the problems are not considered from the aspect of regulating the basic metabolism of a human body, so the effect is not ideal.
Disclosure of Invention
This section is intended to outline some aspects of embodiments of the application and to briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section as well as in the description of the application and in the title of the application, which may not be used to limit the scope of the application.
The present application has been made in view of the above technical drawbacks.
Therefore, as one aspect of the application, the application overcomes the defects in the prior art and provides healthy lipid-reducing meal replacement powder without ketone production and a preparation method thereof.
In order to solve the technical problems, the application provides the following technical scheme: a non-ketogenic healthy lipid-lowering meal replacement powder, wherein: in the meal replacement powder, the energy supply ratio of the carbohydrate is 17-25%, the energy supply ratio of the protein is 25-40%, the energy supply ratio of the fat is 25-38%, and the energy supply ratio of the dietary fiber is 13-20%, so that the meal replacement powder has balanced nutrition, the human body takes fat as an energy source preferentially, the metabolic pathway of the human body can be regulated and controlled accurately, and the generation of ketone bodies is avoided, thereby achieving the purposes of health and fat reduction; the meal replacement powder comprises protein, medium-long chain triglyceride fat, dietary fiber, whole grain powder, fruit powder, nut powder and an additive, wherein the protein accounts for 13.4-53.6% of the meal replacement powder, the medium-long chain triglyceride fat accounts for 8-16% of the meal replacement powder, the dietary fiber accounts for 15-32%, the whole grain powder accounts for 10-14%, the fruit powder accounts for 6-10%, the nut powder accounts for 6-12% of the meal replacement powder, and the additive accounts for 1.4-2.6%.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the medium-long chain triglyceride fat contains medium-long chain triglyceride more than 30%, partial glyceride less than 1% of the fat, saturated fatty acid 25-40%, n-6 polyunsaturated fatty acid 20-40%, and n-3 polyunsaturated fatty acid 4-8%; the medium-long chain triglyceride fat is medium-long chain triglyceride with low partial glyceride content obtained through enzyme catalytic reaction, which is beneficial to promoting the digestion and metabolism of fatty acid, avoiding fat accumulation and prolonging the shelf life of the product.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the protein in the meal replacement powder is derived from one or more of soybean isolated protein, whey protein, egg white protein, whole grain powder, fruit powder and nut powder, wherein the content of the soybean isolated protein is 8-12%, the content of the whey protein is 7-10%, the content of the egg white protein is 4-10%, the protein content of the whole grain powder is 1-2%, the protein content of the fruit powder is 0.3-0.6%, and the protein content of the nut powder is 1.7-4.1%.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the carbohydrate in the meal replacement powder is derived from whole grain powder, fruit powder and nut powder, wherein the whole grain powder provides 7.5-11.5% of carbohydrate, the fruit powder provides 4.5-8.5% of carbohydrate, and the nut powder provides 1.0-1.85% of carbohydrate.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the dietary fiber in the meal replacement powder is one or more of konjac glucomannan, xanthan gum, sodium alginate, whole grain powder, fruit powder and nut powder; wherein, the konjaku gum content is 4-6%, the xanthan gum content is 4-6%, the sodium alginate content is 2-3%, the dietary fiber provided by the whole grain powder is 0.6-0.8%, the dietary fiber provided by the fruit powder is 0.1-0.3%, and the dietary fiber provided by the nut powder is 0.5-1.5%; by adding the enzyme-treated whole grain flour, the fruit flour and the nut flour, on one hand, sufficient dietary fiber, polyphenols and good flavor are provided for the product, and meanwhile, the product has better brewing performance through the hydrolysis of the enzyme.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the fat in the meal replacement powder is one or more of medium-long chain triglyceride fat powder, whole grain powder, fruit powder and nut powder, wherein the fat content of the medium-long chain triglyceride fat powder is 4.5-12%, the fat content of the whole grain powder is 0.3-0.45%, the fat content of the fruit powder is 0.15-0.35%, and the fat content of the nut powder is 2.5-5%.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the additive comprises probiotic powder which is beneficial to intestinal microecology balance, and the content of the probiotic powder is 2-3.5%; wherein the probiotics comprise one or more of bacillus coagulans BC01, lactobacillus plantarum PL15, lactobacillus casei CL05, bifidobacterium lactis NJ241 and lactobacillus rhamnosus NJ 551; the bacillus coagulans BC01 is spore-shaped, has high survival rate after entering the intestinal tract, can germinate rapidly within 4-6 hours, is converted into nutrient bacillus coagulans, consumes oxygen in the intestinal tract in the germination process, competes with harmful flora in the intestinal tract for limited nutrients and living space, and simultaneously generates various lactic acid and coagulants for inhibiting harmful bacteria.
As a preferable scheme of the healthy lipid-reducing meal replacement powder without ketone production, the application comprises the following steps: the essential amino acid, vitamin and mineral substances in the meal replacement powder all meet the requirement of human body, so that the human body reaches nitrogen balance, wherein,
histidine is more than or equal to 564.5mg/100g, isoleucine is more than or equal to 1191.0mg/100g, leucine is more than or equal to 2194.4mg/100g, lysine is more than or equal to 1815.3mg/100g, sulfur-containing amino acid (methionine+cysteine) is more than or equal to 893.6mg/100g, aromatic amino acid (tyrosine+phenylalanine) is more than or equal to 2066.8mg/100g, threonine is more than or equal to 998.9mg/100g, tryptophan is more than or equal to 989.9mg/100g, valine is more than or equal to 1280.8mg/100g;
VA content is not more than 12mg/Kg, VD content is not more than 0.2mg/Kg, VE content is not more than 2.360g/Kg, VK content is not more than 0.32mg/Kg, VB1 content is not more than 5.6mg/Kg, VB6 content is not more than 240mg/Kg, VB12 content is not more than 9.6 μg/Kg, pantothenic acid content is not more than 24mg/Kg, folic acid content is not more than 4mg/Kg, nicotinic acid content is not more than 60mg/Kg, nicotinamide content is not more than 1.240g/Kg, choline content is not more than 8.8g/Kg, biotin content is not more than 0.16mg/Kg, and vitamin C content is not more than 40g/Kg;
the content of calcium is not more than 7.6g/Kg, the content of phosphorus is not more than 13.2g/Kg, the content of potassium is not more than 14.4g/Kg, the content of magnesium is not more than 1.32g/Kg, the content of chlorine is not more than 9.2g/Kg, the content of iron is not more than 168mg/Kg, the content of iodine is not more than 2.4mg/Kg, the content of zinc is not more than 124mg/Kg, the content of selenium is not more than 1.6mg/Kg, the content of copper is not more than 28mg/Kg, the content of fluorine is not more than 12mg/Kg, the content of chromium is not more than 0.12mg/Kg, the content of manganese is not more than 40mg/Kg, and the content of molybdenum is not more than 2mg/Kg.
As one aspect of the application, the application overcomes the defects existing in the prior art, provides a medium-long carbon chain triglyceride with low partial glyceride content,
the medium-long carbon chain triglyceride with low partial glyceride content obtained through the enzyme catalytic reaction is beneficial to promoting the digestion and metabolism of fatty acid, avoiding fat accumulation and prolonging the shelf life of the product; wherein the content of medium-long carbon chain triglyceride is more than 30%, and the content of partial glyceride is less than 1% of the grease;
the medium-long chain triglyceride of the low-fraction glyceride is prepared by transesterification and deacidification of base oil, the preparation process is that the base oil is subjected to random transesterification by adopting Novozym 435 lipase with the enzyme adding amount of 8-15%, the reaction temperature is 30-80 ℃, the time is 3-5 h, and the stirring speed is 300-700 rpm, so as to obtain an intermediate product; adding Lipase G with the pH value of 6.0-7.0, mixing the intermediate product and Lipase G according to the proportion of adding 180-1600U of Lipase G into each liter of intermediate product, fully stirring and reacting for 1-3 hours to hydrolyze part of glyceride at the temperature of 30-80 ℃, centrifuging at a high speed to separate oil and aqueous solution, and carrying out molecular distillation on the enzymolysis product to remove fatty acid, thereby obtaining medium-long carbon chain triglyceride with low part glyceride content, wherein the mass fraction of coconut oil in the base oil is 25-35%, olive oil is 8-20%, linseed oil is 4-12%, sunflower seed oil is 8-25%, and walnut kernel oil is 20-50%;
in the medium-long chain triglyceride of the low-fraction glyceride, the content of saturated fatty acid is 2.5-4%, the energy supply ratio is 7-9.5%, the content of linoleic acid is 2.4-3.3%, the energy supply ratio is 5.9-8.2%, the content of linolenic acid is 0.6-0.75 g/100g%, and the energy supply ratio is 1.75-1.95%. .
As one aspect of the application, the application overcomes the defects existing in the prior art and provides a preparation method of medium-long carbon chain triglyceride powder with low partial glyceride content, which comprises the steps of stirring and dissolving acacia; adding medium-long carbon chain triglyceride with low partial glyceride content, and continuously stirring to form emulsion; homogenizing the emulsion, and then spray-drying to obtain grease powder; the mass ratio of the medium-long carbon chain triglyceride with low partial glyceride content to the acacia gum is 1:1; homogenizing for 5min at 14000 r/min; the solvent for dissolving the acacia gum is water at 60 ℃.
The application has the beneficial effects that:
the formula of the application innovates various creative processes to obtain medium-long carbon chain triglyceride with low partial glyceride content, and the dietary fiber proportion, the prebiotics, the multifunctional mixed probiotics and the like of the whole grain powder, the fruit powder and the nut powder which are easy to brew have the maximum synergistic effect, so that various functional components can play the best effect.
Detailed Description
In order that the above-recited objects, features and advantages of the present application will become more apparent, a more particular description of the application will be rendered by reference to specific embodiments thereof.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present application, but the present application may be practiced in other ways other than those described herein, and persons skilled in the art will readily appreciate that the present application is not limited to the specific embodiments disclosed below.
Further, reference herein to "one embodiment" or "an embodiment" means that a particular feature, structure, or characteristic can be included in at least one implementation of the application. The appearances of the phrase "in one embodiment" in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments.
Example 1
Selection of Novoz y The m 435 lipase performs random transesterification on the compound vegetable oil to prepare medium-long carbon chain triglyceride, the reaction condition is that the enzyme adding amount is 8% -15%, the reaction temperature is 60 ℃ and the time is 5 hours, and the lipase is recovered through high-speed centrifugal filtration. Lipase G (by Amano Enz y Obtained by fermentation of Penicillium camelerti produced by me Inc.) is arranged at a ratio of 3000 to 8000U/LAnd (3) regulating the pH value of the aqueous solution to 6.0-7.0 by using a phosphate buffer solution, mixing the enzyme reaction intermediate product with the aqueous solution of Lipase G according to the volume ratio of 10 (0.6-2), fully stirring and reacting for 1-3 hours at the temperature of 40-50 ℃ to hydrolyze part of glyceride, and centrifuging at a high speed to separate oil from the aqueous solution. And (3) carrying out molecular distillation on an enzymolysis product obtained by hydrolyzing Lipase G to remove fatty acid, thus obtaining the medium-long carbon chain triglyceride with low partial glyceride content.
Table 1.1 Compound vegetable oil composition volume ratio (%)
Sequence number | Coconut oil | Linseed oil | Walnut kernel oil | Olive oil | Sunflower seed oil |
1 | 35 | 10 | 15 | 40 | 0 |
2 | 20 | 2 | 25 | 53 | 0 |
3 | 45 | 13 | 20 | 22 | 0 |
4 | 20 | 4 | 24 | 32 | 20 |
5 | 25 | 6 | 50 | 9 | 10 |
6 | 35 | 10 | 20 | 20 | 15 |
TABLE 1.2 parameters of the enzymatic transesterification and hydrolysis process for compounding vegetable oils
TABLE 1.3 composition ratio of glycerides in fat after transesterification (%)
Dissolving acacia in distilled water at 60 ℃, magnetically stirring until the acacia is fully dissolved, slowly adding medium-long carbon chain triglyceride with low partial glyceride content, continuously stirring to prepare emulsion with the acacia and the medium-long carbon chain triglyceride accounting for 25%, homogenizing the emulsion on a homogenizer at 14000r/min for 5min, and performing spray drying to obtain powder grease with the ratio of grease to acacia being 1:1.
TABLE 1.4 fatty acid composition and energy supply ratio of powdered oil and fat with number 4
Fatty acid | Formula oil | Fatty acid composition (%) | Energy supply ratio (%E) |
C4:0 | 0.0 | 0.07 | 0.03 |
C6:0 | 0.0 | 0.06 | 0.02 |
C8:0 | 1.1 | 1.14 | 0.40 |
C10:0 | 1.1 | 1.18 | 0.41 |
C12:0 | 9.5 | 9.18 | 3.21 |
C14:0 | 3.9 | 3.95 | 1.38 |
C16:0 | 8.2 | 8.26 | 2.89 |
C16:1 | 0.3 | 0.34 | 0.12 |
C17:0 | 0.0 | 0.05 | 0.02 |
C17:1 | 0.0 | 0.03 | 0.01 |
C18:0 | 3.0 | 3.23 | 1.13 |
C18:1 | 38.2 | 38.16 | 13.35 |
C18:2n-6 | 28.7 | 28.23 | 9.87 |
C18:3n-3 | 4.9 | 4.72 | 1.65 |
Saturated fatty acids | 27.0 | 27.1 | 9.5 |
TABLE 1.5 fatty acid composition and energy supply ratio of powder oil obtained by No. 5
TABLE 1.6 fatty acid composition and energy supply ratio of powdered oil and fat with serial number 6
Fatty acid | Formula oil | Fatty acid composition (%) | Energy supply ratio (%E) |
C4:0 | 0.0 | 0.32 | 0.07 |
C6:0 | 0.0 | 0.26 | 0.05 |
C8:0 | 2.0 | 1.99 | 0.41 |
C10:0 | 1.9 | 2.23 | 0.46 |
C12:0 | 16.7 | 15.07 | 3.10 |
C14:0 | 6.8 | 7.05 | 1.45 |
C16:0 | 8.2 | 9.04 | 1.86 |
C16:1 | 0.2 | 0.37 | 0.08 |
C17:0 | 0.0 | 0.05 | 0.01 |
C17:1 | 0.0 | 0.03 | 0.01 |
C18:0 | 3.0 | 3.72 | 0.77 |
C18:1 | 28.7 | 29.26 | 6.02 |
C18:2n-6 | 24.0 | 22.92 | 4.72 |
C18:3n-3 | 7.7 | 6.91 | 1.42 |
Saturated fatty acids | 38.7 | 39.7 | 8.2 |
After the treatment, the fatty acid energy supply ratio of the powder grease obtained by the serial numbers 1-6 is less than 10, the n-6 polyunsaturated fatty acid energy supply ratio is 2.5-9.0%, and the n-3 polyunsaturated fatty acid energy supply ratio is 0.5-2.0% when the saturated fatty acid energy supply ratio meets the requirements in the reference intake of dietary nutrients of residents in China.
Example 2
The basic formula of the embodiment comprises, by mass, 30 parts of protein (10 parts of soy protein isolate, 10 parts of whey protein and 10 parts of egg white protein respectively), 10 parts of dietary fiber (40%, 40% and 20% of konjac gum, xanthan gum and sodium alginate respectively) 20 parts of medium-long chain fatty powder obtained in the sequence number 1 in the embodiment 1, 10 parts of whole grain powder, 10 parts of fruit powder, 10 parts of nut powder and 9 parts of additives (the mass ratio of each additive is soybean lecithin: L-arabinose: stachyose: probiotic powder: vitamin: sucralose: erythritol=1:0.5:0.5:2.5:1:3.5:0.2:0.8). And (3) fully stirring and uniformly mixing all the weighed material powder.
Wherein, each component and proportion in the whole grain powder, the fruit powder and the nut powder are shown in the following table 2.1.
Cereal flour, fruit flour and nut flour were prepared as follows:
removing impurities from grains, cleaning, transferring to shallow tank container, accelerating germination, culturing at 30deg.C, spraying distilled water to keep rice moist, culturing to bud length of 0.5-1mm, oven drying in 40 deg.C heat pump drying oven, hulling Gu Quchu rice husk with huller, pulverizing germinated brown rice with pulverizer, and sieving with 60 mesh sieve. Weighing 40-50U/g of high-temperature alpha-amylase solution, dissolving in distilled water accounting for 10-15% of the mass of the grains, and uniformly mixing with germinated grain raw materials. Extruding and puffing the materials by a double-screw puffing machine, collecting an extruded sample after discharging is stable, drying at the constant temperature of 55 ℃, crushing the dried sample, and sieving the crushed sample with a 40-mesh sieve;
crushing the impurity-removed shell-free nut raw material, regulating the water content to 10% -20%, adding 2.5% -3.5% of mixed enzyme containing cellulase and protease, uniformly mixing, wherein the proportion of the two enzymes is 8:2, carrying out enzymolysis for 20-30 min, extruding and puffing the material by a double-screw puffing machine, collecting an extruded sample after discharging is stable, drying at the constant temperature of 55 ℃, crushing the dried sample, and sieving by a 40-mesh sieve;
cleaning fruit raw materials, pulping, adding 0.2-0.3 g/kg of ascorbic acid to protect the color of the fruit juice, and adding 2-3% of pectase and cellulase into the fruit juice, uniformly mixing, wherein the ratio of pectase to cellulase is 4:6, carrying out enzymolysis for 15-20 min, and carrying out vacuum freeze drying on the materials under the following drying conditions: the pre-freezing temperature is-40 ℃, the vacuum degree is 10Pa, and the sublimation heating temperature is 50 ℃.
TABLE 2.1 formulation of base materials and chemical composition thereof
Whole grain flour | Mass fraction/% | Fruit powder | Mass fraction/% | Nut meal | Mass fraction/% |
Brown rice | 30 | Apple tree | 30 | Peanut | 30 |
Black rice | 10 | Litchi fruit | 20 | Walnut | 10 |
Millet | 20 | Grape | 20 | Pine nut | 10 |
Highland barley | 10 | Mango | 20 | Almond | 30 |
Oat (oat) | 20 | Strawberry | 10 | Hazelnut | 20 |
Buckwheat | 10 |
Through detection, the content of the components of the meal replacement powder obtained in the embodiment can provide energy with the ratio shown in table 2.2, and the content of essential amino acids, fatty acids, vitamins and minerals in the healthy lipid-lowering meal replacement powder formula without ketone production is detected, and the result is shown in tables 2.3-2.5. As can be seen from the table, the meal replacement powder of this example has a protein energy ratio of about 38.13%, a carbohydrate energy ratio of 18.78%, a dietary fiber energy ratio of 13.45%, and a fat energy ratio of 29.64%. The saturated fatty acid energy supply ratio in the meal replacement powder is 9.36%, the C18:2n-6 and C18:3n-3 energy supply ratios are 5.96% and 1.75%, respectively, and the requirements of the reference intake (2013 edition) of Chinese resident dietary nutrients on the energy supply ratio of saturated fatty acid (< 10%) n-6 polyunsaturated fatty acid (2.5-9%) and n-3 polyunsaturated fatty acid (0.2-2%) are met.
TABLE 2.2 chemical composition and energy supply ratio of meal replacement powder
Proteins | Carbohydrates | Dietary fiber | Fat | |
Example 2 | 5.37 | 17.43 | 2.94 | 4.21 |
Material ratio/% | 35.38 | 17.43 | 24.96 | 12.22 |
Energy ratio/% | 38.13 | 18.78 | 13.45 | 29.64 |
TABLE 2.3 essential amino acid composition in non-ketogenic healthy fat-reducing meal replacement powders
TABLE 2.4 Mass fraction, content and energy ratio of fatty acids in non-ketogenic healthy fat-reducing meal replacement powder
Mass fractionNumber (%) | Content (g/100 g materials) | Energy ratio (%) | |
C8:0 | 1.31 | 0.16 | 0.39 |
C10:0 | 1.27 | 0.16 | 0.38 |
C12:0 | 10.93 | 1.34 | 3.24 |
C14:0 | 4.43 | 0.54 | 1.31 |
C16:0 | 8.83 | 1.08 | 2.62 |
C16:1 | 0.29 | 0.04 | 0.09 |
C18:0 | 4.83 | 0.59 | 1.43 |
C18:1 | 42.08 | 5.14 | 12.47 |
C18:2n-6 | 20.12 | 2.46 | 5.96 |
C18:3n-3 | 5.92 | 0.72 | 1.75 |
Saturated fatty acids | 31.59 | 3.86 | 9.36 |
TABLE 2.5 detection of vitamins and minerals contained in healthy, reduced-fat meal replacement powder without ketogenesis
Example 3
The basic formula of the embodiment comprises, by mass, 21 parts of protein (soy protein isolate: whey protein: egg white protein=8:7:6), 15 parts of dietary fiber (konjac gum, xanthan gum and sodium alginate, which are compounded to form the product with the weight ratio of 40%, 40% and 20% respectively, namely, 6% and 3% of konjac gum, xanthan gum and sodium alginate in the meal replacement dietary fiber), 30 parts of long-chain fatty powder in sequence number 2 in the embodiment 1, 12 parts of whole grain powder, 6 parts of fruit powder, 6 parts of nut powder and 6 parts of additives (the mass ratio of each additive is that soybean lecithin: L-arabinose: stachyose, probiotic powder: vitamin: mineral: sucralose: erythritol=0.8:0.8:0.8:0.3:2:1.2:4:0.3:0.6).
The components and proportions of the whole grain flour, the fruit flour and the nut flour are shown in the following table 3.1:
TABLE 3.1 formulation of base materials and chemical composition thereof
Whole grain flour | Mass fraction/% | Fruit powder | Mass fraction/% | Nut meal | Mass fraction/% |
Brown rice | 20 | Apple tree | 40 | Peanut | 20 |
Black rice | 20 | Litchi fruit | 15 | Walnut | 20 |
Millet | 10 | Grape | 15 | Pine nut | 30 |
Highland barley | 20 | Mango | 15 | Almond | 20 |
Oat (oat) | 10 | Strawberry | 15 | Hazelnut | 10 |
Buckwheat | 20 |
The meal replacement powder prepared by the embodiment can provide about 26% of protein energy supply ratio, 17% of carbohydrate energy supply ratio, 19% of dietary fiber energy supply ratio and 37% of fat energy supply, and meanwhile, the balance of amino acid and fatty acid of a human body is achieved (according with the reference intake of dietary nutrients of Chinese residents). The saturated fatty acid energy supply ratio in the meal replacement powder is 9.22%, the C18:2n-6 and C18:3n-3 energy supply ratios are 8.14% and 1.69%, respectively, and the requirements of the reference intake (2013 edition) of Chinese resident dietary nutrients on the energy supply ratio of saturated fatty acid (< 10%) n-6 polyunsaturated fatty acid (2.5-9%) and n-3 polyunsaturated fatty acid (0.2-2%) are met. The essential amino acids, fatty acids, vitamins and minerals of the meal replacement powder of this example were tested and the results are shown in tables 3.3 to 3.5.
TABLE 3.2 chemical composition and energy supply ratio of meal replacement powder
TABLE 3.3 essential amino acid composition in meal replacement powder
TABLE 3.4 mass fraction, content and energy ratio of fatty acids in meal replacement powder
Mass fraction (%) | Content (g/100 g materials) | Energy ratio (%) | |
C8:0 | 0.91 | 0.14 | 0.34 |
C10:0 | 0.89 | 0.13 | 0.33 |
C12:0 | 7.61 | 1.14 | 2.82 |
C14:0 | 3.09 | 0.46 | 1.14 |
C16:0 | 8.85 | 1.33 | 3.28 |
C16:1 | 0.40 | 0.06 | 0.15 |
C18:0 | 3.52 | 0.53 | 1.31 |
C18:1 | 48.22 | 7.25 | 17.88 |
C18:2n-6 | 21.96 | 3.30 | 8.14 |
C18:3n-3 | 4.56 | 0.69 | 1.69 |
Saturated fatty acids | 24.86 | 3.74 | 9.22 |
TABLE 3.5 composition of vitamins and minerals in meal replacement powder
Vitamins | Content (mg/Kg) | Mineral substances | Content (mg/Kg) |
VA | 12.1 | Calcium | 7169 |
VD | 0.22 | Phosphorus (P) | 10788 |
VE | 1650 | Potassium | 11197 |
VK | 0.30 | Magnesium (Mg) | 1269 |
VB1 | 5.7 | Chlorine | 9188 |
VB2 | 5.6 | Iron (Fe) | 170 |
VB6 | 203 | Iodine | 2.2 |
VB12 | 9.9(μg/Kg) | Zinc alloy | 80.5 |
Pantothenic acid | 16.5 | Selenium (Se) | 1.4 |
Folic acid | 2.4 | Copper (Cu) | 24 |
Nicotinic acid | 60.7 | Fluorine (F) | 10.5 |
Nicotinamide | 1233 | Chromium (Cr) | 0.13 |
Choline choline | 4789 | Manganese (Mn) | 26 |
Biotin | 0.16 | Molybdenum (Mo) | 2.1 |
Example 4
The basic formula of the instant embodiment comprises, by mass, 25 parts of protein (soy protein isolate: whey protein: egg white protein=12:9:4), 13 parts of dietary fiber (konjac gum, xanthan gum and sodium alginate, which are compounded by mixing 40%, 40% and 20% of each, namely 5.2%,5.2% and 2.6% of konjac gum, xanthan gum and sodium alginate in dry dietary fiber of meal replacement powder), 12 parts of long-chain fatty powder in sequence number 3, 14 parts of whole grain powder, 10 parts of fruit powder, 12 parts of nut powder and 9 parts of additives (the mass ratio of each additive is soy lecithin: L-arabinose: stachyose: probiotic powder: vitamin: sucralose: erythritol=1.5:1.2:1.2:2:2:3.5:1.5:4.5:0.5).
Wherein, each component and the proportion of the whole grain powder, the fruit powder and the nut powder are as follows in table 4.1:
TABLE 4.1 formulation of base materials and chemical composition thereof
The meal replacement powder provided by the embodiment can provide about 35% of protein energy supply ratio, 24% of carbohydrate energy supply ratio, 13% of dietary fiber energy supply ratio and 26% of fat energy supply, and meanwhile, the balance of amino acid and fatty acid of a human body is achieved (according with the reference intake of dietary nutrients of Chinese residents). The saturated fatty acid energy supply ratio in the meal replacement powder is 7.25%, the C18:2n-6 and C18:3n-3 energy supply ratios are 6.62% and 1.93%, respectively, and the requirements of the reference intake (2013 edition) of Chinese resident dietary nutrients on the energy supply ratio of saturated fatty acid (< 10%) n-6 polyunsaturated fatty acid (2.5-9%) and n-3 polyunsaturated fatty acid (0.2-2%) are met.
TABLE 4.2 chemical composition and energy supply ratio of meal replacement powder
Proteins | Carbohydrates | Dietary fiber | Fat | |
Example 4 | 6.19 | 20.99 | 3.34 | 5.48 |
Ratio of substances | 31.18 | 20.99 | 23.53 | 10.29 |
Energy ratio | 35.80 | 24.10 | 13.51 | 26.59 |
TABLE 4.3 essential amino acid composition in meal replacement powder
TABLE 4.4 mass fraction, content and energy ratio of fatty acids in meal replacement powder
/>
TABLE 4.5 composition of vitamins and minerals in meal replacement powder
Vitamins | Content (mg/Kg) | Mineral substances | Content (mg/Kg) |
VA | 8.1 | Calcium | 7580 |
VD | 0.3 | Phosphorus (P) | 13180 |
VE | 2345 | Potassium | 13500 |
VK | 0.30 | Magnesium (Mg) | 1180 |
VB1 | 5.2 | Chlorine | 9186 |
VB2 | 4.6 | Iron (Fe) | 75 |
VB6 | 116 | Iodine | 0.43 |
VB12 | 9.3(μg/Kg) | Zinc alloy | 29.8 |
Pantothenic acid | 19.7 | Selenium (Se) | 0.22 |
Folic acid | 4.1 | Copper (Cu) | 3.1 |
Nicotinic acid | 58 | Fluorine (F) | 5.5 |
Nicotinamide | 1202 | Chromium (Cr) | 0.11 |
Choline choline | 8789 | Manganese (Mn) | 17.3 |
Biotin | 0.11 | Molybdenum (Mo) | 0.41 |
Vitamin C | 2356 |
Example 5:
the sensory evaluation is carried out by adopting a double-blind method, each sample is repeated three times, and sensory evaluation standards are formulated according to the color, the flavor, the taste and the brewing degree of the product, and the overall acceptance is used as an overall evaluation index. Sensory scoring criteria are shown in the table.
TABLE 5.1 sensory scoring criteria
TABLE 5.2 scoring condition
Example 6: human body experiment evaluation
The meal replacement powders of examples 2 to 4 were subjected to human experiments, the study subjects were 12 persons in total, 4 persons in each group, all the subjects were overweight (BMI > 24), the diet of the subjects was intervened, 250g were taken daily by each person, and human composition tests were performed before and at the end of the intervention, respectively.
TABLE 6.1 test results of obesity related indicators before and after intervention
According to the metabolic characteristics of the human body, based on the accurate limit of nutrient components, various lipid-reducing meal powder formulas which are balanced in macro and micro nutrients and can accurately regulate and control basic metabolic pathways of the human body are designed, so that the human body takes fat as an energy source preferentially, and meanwhile, the generation of ketone bodies is avoided, and the purposes of healthy lipid reduction are achieved; the medium-long carbon chain triglyceride with low partial glyceride content obtained by the enzyme catalytic reaction is taken as a main fat source in the formula, which is beneficial to promoting the rapid digestion and metabolism of fatty acid, avoiding fat accumulation and prolonging the shelf life of the product; the enzyme-treated whole grain flour, fruit flour and nut flour are added, so that the product has better brewing performance while providing sufficient dietary fiber, polyphenols and good flavor; the viscosity of the dietary fiber is increased by optimizing the proportion of the dietary fiber and utilizing the synergistic effect of the dietary fiber, so that the postprandial glycemic index is stabilized, and the insulin resistance is relieved; the prebiotics and the multifunctional mixed probiotics are added into the formula, and the intestinal microecology balance is maintained together through the synergistic effect of the prebiotics and the multifunctional mixed probiotics. The meal replacement powder obtained by the application has the advantages of high speed of reducing fat and blood sugar, obvious effect and no obvious side effect.
The optimized formula of the fat-reducing meal replacement powder is characterized in that after entering a human body, the human body takes fat as an energy source preferentially, and meanwhile, due to the fact that a proper amount of carbohydrate exists, the production of ketone bodies can be well avoided by utilizing intermediate metabolites of the carbohydrate, so that the purpose of healthy fat reduction is achieved; the medium-long carbon chain triglyceride with low partial glyceride content obtained through the enzyme catalytic reaction is beneficial to promoting the digestion and metabolism of fatty acid, avoiding fat accumulation and prolonging the shelf life of the product; by adding the enzyme-treated whole grain powder, the fruit powder and the nut powder, on one hand, sufficient dietary fiber, polyphenol substances and good flavor are provided for the product, and meanwhile, the product has better brewing performance through the hydrolysis of the enzyme; by optimizing the proportion of the dietary fibers, the viscosity of the dietary fibers is increased by utilizing the synergistic effect of the dietary fibers, the blood glucose load of the product is improved, the postprandial glycemic index is stabilized, and the insulin resistance is relieved; the prebiotics and the probiotics are added in the formula, and the intestinal microecology balance is maintained through the synergistic effect between the prebiotics and the probiotics.
The meal replacement powder is added with probiotics powder which is beneficial to intestinal microecology balance, the content of the probiotics powder is 2-3.5%, the probiotics comprises bacillus coagulans BC01, lactobacillus plantarum PL15, lactobacillus casei CL05, bifidobacterium lactis NJ241 and lactobacillus rhamnosus NJ551, wherein the proportion of the bacillus coagulans BC01 is 10-20%, the proportion of the lactobacillus plantarum PL15 is 10-20%, the proportion of the lactobacillus casei CL05 is 10-30%, the proportion of the bifidobacterium lactis NJ241 is 10-30%, and the proportion of the lactobacillus rhamnosus NJ551 is 20-30%; the bacillus coagulans BC01 is spore-state, has high survival rate after entering the intestinal tract, can germinate rapidly within 4-6 hours, is converted into nutrient bacillus coagulans, firstly consumes oxygen in the intestinal tract in the germination process, contends with the harmful flora in the intestinal tract for limited nutrients and living space, and simultaneously generates various lactic acid and coagulants for inhibiting harmful bacteria; lactobacillus plantarum PL15 is a facultative anaerobe, and generates specific lactobacillus, inhibits pathogenic bacteria, maintains intestinal balance and promotes nutrient absorption; the lactobacillus casei CL05 resists gastric acid and bile salts, can exist in a large amount in intestinal tracts, adjusts the balance of intestinal flora, prevents constipation and cell aging, and promotes digestion and absorption of human bodies; the bifidobacterium lactis NJ241 can inhibit the growth of intestinal putrefying bacteria by regulating the normal flora of the intestinal tract, so that the generation of some intestinal carcinogens is reduced, and the carcinogenic and mutagenic substances in food can be adsorbed, so that body cells are protected from being damaged by the carcinogens; lactobacillus rhamnosus can enter human intestinal tract in living body, survive and colonize in human intestinal tract, promote growth of bifidobacterium and lactobacillus acidophilus, balance and improve intestinal function, and prevent and treat diarrhea.
The stachyose is added in the application, which has obvious proliferation effect on beneficial bacteria such as bifidobacteria, lactobacillus and the like in human gastrointestinal tracts, can rapidly improve the environment in human digestive tracts, and can regulate the balance of microecological bacteria. The preparation method can promote the formation of dominant bacteria of beneficial bacteria in the alimentary canal, inhibit the production of putrefying bacteria such as clostridium acidogenes and the like, generate a large amount of physiologically active substances, regulate the pH value of intestinal tracts, kill pathogenic bacteria, repress the generation of putrefying products, inhibit the generation and absorption of endogenous cancerogens, and decompose and derive multiple immune function factors; the added L-arabinose can inhibit enzyme for hydrolyzing disaccharide, so that the rise of blood sugar caused by sucrose intake is inhibited, meanwhile, due to the inhibition of the L-arabinose on the disaccharide hydrolase, sucrose which is not decomposed in the small intestine is decomposed by microorganisms in the large intestine to generate a large amount of organic acid, and the organic acid has inhibition effect on liver synthetic fat, and the inhibition effect of the L-arabinose on sucrose absorption in the small intestine is also carried out, so that the generation of new fat in the body is reduced. The raw materials also comprise other food additives which affect the taste, flavor and texture of meal replacement powder, and the food additives comprise 0.8-1.5% of soybean lecithin, 0.1-0.3% of sucralose and 0.5-0.8% of erythritol.
Therefore, the patent optimizes the basic formula of the healthy fat-reducing meal replacement powder with low carbon water, high protein and high dietary fiber, and realizes the accurate regulation and control of human metabolism: the formula is characterized in that the medium-long carbon chain triglyceride with low partial glyceride content, the whole grain powder, the fruit powder and the nut powder which are easy to brew and have the maximum synergistic effect are innovated through various creative processes, the dietary fiber proportion is coupled with prebiotics, multifunctional mixed probiotics and the like, so that various functional components exert the optimal effect.
Through optimizing the composition of various nutrients, the balance of various nutrients is finally realized, so that amino acid, fatty acid, mineral substances, vitamins and the like all meet the recommended standard of the reference intake of dietary nutrients of Chinese residents; the medium-long carbon chain triglyceride with low partial glyceride content, which is obtained by adding enzyme reaction, is beneficial to promoting the digestion and metabolism of fatty acid, avoiding fat accumulation and prolonging the shelf life of the product; the whole grain powder, the fruit powder and the nut powder treated by enzyme are added in the formula, so that the brewing performance of the product is better while the dietary fiber and the flavor of the product are improved; the formula utilizes the synergistic effect of dietary fibers to increase the viscosity of the dietary fibers by optimizing the proportion of the dietary fibers, so that the blood glucose load of the product is improved, the postprandial glycemic index is stabilized, and the insulin resistance is relieved; meanwhile, prebiotics and probiotics are added in the formula, and intestinal microecological balance is maintained through the synergistic effect of the prebiotics and the probiotics.
It should be noted that the above embodiments are only for illustrating the technical solution of the present application and not for limiting the same, and although the present application has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that the technical solution of the present application may be modified or substituted without departing from the spirit and scope of the technical solution of the present application, which is intended to be covered in the scope of the claims of the present application.
Claims (5)
1. A healthy lipid-reducing meal replacement powder without ketone production is characterized in that: in the meal replacement powder, the energy supply ratio of carbohydrate is 17-25%, the energy supply ratio of protein is 25-40%, the energy supply ratio of fat is 25-38%, and the energy supply ratio of dietary fiber is 13-20%; the meal replacement powder comprises protein, medium-long chain triglyceride fat, dietary fiber, whole grain powder, fruit powder, nut powder and additives, wherein the protein accounts for 13.4-53.6% of the meal replacement powder, the medium-long chain triglyceride fat accounts for 8-16% of the meal replacement powder, the dietary fiber accounts for 15-32%, the whole grain powder accounts for 10-14%, the fruit powder accounts for 6-10%, the nut powder accounts for 6-12% of the meal replacement powder, and the additives account for 1.4-2.6%;
wherein, medium-long carbon chain triglyceride with low partial glyceride content is obtained by enzyme catalysis reaction; the medium-long chain triglyceride of the low-fraction glyceride is prepared by transesterification and deacidification of base oil, the preparation process is that the base oil is subjected to random transesterification by adopting Novozym 435 lipase with the enzyme adding amount of 8-15%, the reaction temperature is 30-80 ℃, the time is 3-5 h, and the stirring speed is 300-700 rpm, so as to obtain an intermediate product; adding Lipase G with the pH value of 6.0-7.0, mixing the intermediate product with Lipase G according to the proportion of adding 180-1600U of Lipase G into each liter of intermediate product, fully stirring and reacting for 1-3 hours at the temperature of 30-80 ℃ to hydrolyze part of glyceride, centrifuging at a high speed to separate oil from aqueous solution, and carrying out molecular distillation on enzymolysis products to remove fatty acid, thus obtaining medium-length carbon chain triglyceride with low partial glyceride content; according to mass fraction, 25-35% of coconut oil, 8-20% of olive oil, 4-12% of linseed oil, 8-25% of sunflower seed oil and 20-50% of walnut kernel oil in the base oil.
2. The non-ketogenic healthy lipid-lowering meal replacement powder of claim 1, wherein: the medium-long chain triglyceride content in the medium-long chain triglyceride fat is more than 30%, the partial glyceride content is less than 1% of the fat, the saturated fatty acid content is 25-40%, the n-6 polyunsaturated fatty acid content is 20-40%, and the n-3 polyunsaturated fatty acid content is 4-8%.
3. The non-ketogenic healthy lipid-lowering meal replacement powder according to claim 1 or 2, characterized in that: the protein in the meal replacement powder is derived from one or more of soybean isolated protein, whey protein and egg white protein, wherein the content of the soybean isolated protein is 8-12%, the content of the whey protein is 7-10%, and the content of the egg white protein is 4-10%.
4. The non-ketogenic healthy lipid-lowering meal replacement powder according to claim 1 or 2, characterized in that: dietary fibers in the meal replacement powder are derived from one or more of konjac glucomannan, xanthan gum and sodium alginate; wherein, the content of konjak gum is 4-6%, the content of xanthan gum is 4-6%, and the content of sodium alginate is 2-3%.
5. The non-ketogenic healthy lipid-lowering meal replacement powder according to claim 1 or 2, characterized in that: the additive comprises probiotic powder which is beneficial to intestinal microecology balance; wherein the probiotics comprise one or more of bacillus coagulans BC01, lactobacillus plantarum PL15, lactobacillus casei CL05, bifidobacterium lactis NJ241 and lactobacillus rhamnosus NJ 551.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010506274.3A CN112006273B (en) | 2020-06-05 | 2020-06-05 | Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010506274.3A CN112006273B (en) | 2020-06-05 | 2020-06-05 | Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112006273A CN112006273A (en) | 2020-12-01 |
CN112006273B true CN112006273B (en) | 2023-10-03 |
Family
ID=73506670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010506274.3A Active CN112006273B (en) | 2020-06-05 | 2020-06-05 | Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112006273B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114009786B (en) * | 2021-11-22 | 2023-04-07 | 江南大学 | Nutritional oil composition for vitamin D delivery, preparation method and application |
WO2024018421A1 (en) * | 2022-07-21 | 2024-01-25 | Biosfera Nature S.R.L. | Dietetic food product and method for the production thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101115831A (en) * | 2005-01-19 | 2008-01-30 | 日清奥利友集团株式会社 | Method for producing a purified lipase |
CN103060086A (en) * | 2012-12-17 | 2013-04-24 | 华南理工大学 | Method for removing metaglyceride from grease |
CN103897811A (en) * | 2014-04-02 | 2014-07-02 | 河北康睿达脂质有限公司 | Production method for medium-chain and long-chain oil fatty acid |
CN106418544A (en) * | 2016-06-30 | 2017-02-22 | 山东凤凰生物有限公司 | Protein and probiotic composite food with weight losing effect |
CN109645320A (en) * | 2019-02-28 | 2019-04-19 | 北京万莱康营养与健康食品科学技术研究院有限公司 | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201210699D0 (en) * | 2012-06-15 | 2012-08-01 | Vitaflo Ltd | Nutritional food |
-
2020
- 2020-06-05 CN CN202010506274.3A patent/CN112006273B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101115831A (en) * | 2005-01-19 | 2008-01-30 | 日清奥利友集团株式会社 | Method for producing a purified lipase |
CN103060086A (en) * | 2012-12-17 | 2013-04-24 | 华南理工大学 | Method for removing metaglyceride from grease |
CN103897811A (en) * | 2014-04-02 | 2014-07-02 | 河北康睿达脂质有限公司 | Production method for medium-chain and long-chain oil fatty acid |
CN106418544A (en) * | 2016-06-30 | 2017-02-22 | 山东凤凰生物有限公司 | Protein and probiotic composite food with weight losing effect |
CN109645320A (en) * | 2019-02-28 | 2019-04-19 | 北京万莱康营养与健康食品科学技术研究院有限公司 | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
"Preparation of structured lipids enriched withmedium- and long-chain triacylglycerols byenzymatic interesterification for infant formulaformula";Sameh A. Korma,等;《Food and Bioproducts Processing》;20181231;第107卷;第121-130页 * |
中长碳链甘油三酯的研究进展;周飞等;《中国油脂》;20181231(第07期);第67-71、81页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112006273A (en) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Verni et al. | Fermentation biotechnology applied to cereal industry by-products: Nutritional and functional insights | |
CN102026554B (en) | Lactobacillus paracasei and weight control | |
CN1271936C (en) | Symbiotic functional food | |
Ashayerizadeh et al. | Effect of dietary supplementation of probiotic and prebiotic on growth indices and serum biochemical parameters of broiler chickens | |
Feng et al. | Evolution of okara from waste to value added food ingredient: An account of its bio-valorization for improved nutritional and functional effects | |
CN111084381A (en) | Ketogenic nutritional meal replacement powder and application | |
CN112006273B (en) | Healthy lipid-reducing meal replacement powder free of ketone production and preparation method thereof | |
JP2013515051A (en) | Non-fermenting compositions comprising cereal-based fractions and probiotics and their use | |
CN111728195B (en) | Low-carbon, non-ketogenic, lipid-reducing and blood-sugar-reducing meal replacement milk shake and preparation method thereof | |
CN106615933A (en) | Premix mate for laying hens in egg producing period and preparation and application of premix mate | |
CN109846035A (en) | A kind of compound probiotic composition with body weight control | |
CN112877172B (en) | Method for preparing nutritious healthy black vinegar juice | |
CN102940014A (en) | Production method of health care moon cake containing purple potato and oat and stuffing | |
Zhai et al. | Fermentation of flaxseed cake increases its nutritional value and utilization in ducklings | |
CN108283285A (en) | A kind of health-care physiotherapeutic food of diabetes | |
US20190262415A1 (en) | Supplement for inducing and sustaining nutritional ketosis | |
CN107156238A (en) | A kind of mushroom biscuit and preparation method thereof | |
de Souza Aquino et al. | Models to evaluate the prebiotic potential of foods | |
CN112617083A (en) | Prebiotics solid beverage capable of relaxing bowel and reducing blood sugar and preparation method thereof | |
KR101133208B1 (en) | Method Manufacturing of Functional Fermented Soybean materials for improving the intestine function and constipation Using Plant?Originated Lactic Acid Bacteria and Bacillus | |
CN104757535A (en) | Lycium ruthenicum slimming tablet (tea) | |
CN111728003B (en) | Crisp meal replacement biscuit capable of reducing fat and reducing blood glucose and preparation method thereof | |
CN112021369B (en) | Nutritional meal replacement biscuit with low Glycemic Index (GI) and industrial mass production method thereof | |
Peres et al. | Role of natural fermented olives in health and disease | |
Salovaara et al. | Fermented cereal-based functional foods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210526 Address after: Room 2345, 23 / F, unit 11, building 1, No.8, Section 1, Jinhua Road, Jinjiang District, Chengdu, Sichuan 610000 Applicant after: CHENGDU TIANYI MEISHAN NUTRITION FOOD Co.,Ltd. Applicant after: Jiangnan University Address before: No. 1800 road 214122 Jiangsu Lihu Binhu District City of Wuxi Province Applicant before: Jiangnan University |
|
GR01 | Patent grant | ||
GR01 | Patent grant |